Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis

详细信息    查看全文

• 作者：Nicolás Casellas-Cabrera ; Yaritza Díaz-Algorri ; Víctor J. Carlo-Chévere…
• 关键词：Adenomatous polyposis coli ; Thyroid cancer ; Cribriform–morular variant of papillary thyroid cancer (CMV ; PTC) ; β ; Catenin ; Familial adenomatous polyposis ; Hispanics
• 刊名：Familial Cancer
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：15
• 期：2
• 页码：267-274
• 全文大小：581 KB
• 参考文献：1.Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10(7):721–733CrossRef PubMed
  2.Reed TE, Neel JV (1955) A genetic study of multiple polyposis of the colon with an appendix deriving a method of estimating relative fitness. Am J Hum Genet 7(3):236–263PubMed PubMedCentral
  3.Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, Kleibeuker JH, Witjes MJ, Links TP, van Beek AP (2008) Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol 15(9):2439–2450. doi:10.​1245/​s10434-008-9981-3 CrossRef PubMed PubMedCentral
  4.SEER Stat Fact Sheets: Thyroid Cancer (2015) National Cancer Institute, Rockville. http://​seer.​cancer.​gov/​statfacts/​html/​thyro.​html . Accessed December 4, 2015
  5.Tortolero-Luna G, Zavala-Zegarra D, Perez-Rios N, Torres-Cintron CR, Ortiz-Ortiz KJ, Traverso-Ortiz M, Veguilla-Rosario I, Vazquez-Cubano N, Merced-Velez MF, Ojeda-Reyes G, Hayes-Velez FJ, Ramos-Cordero M, Lopez-Rodriguez A, Perez-Rosa N (2013) Cancer in Puerto Rico: 2006–2010. Puerto Rico Central Cancer Registry, San Juan
  6.Ramirez-Vick M, Nieves-Rodriguez M, Lugaro-Gomez A, Perez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico, 1985-2004. P R Health Sci J 30(3):109–115PubMed
  7.Holt EH (2010) Care of the pregnant thyroid cancer patient. Curr Opin Oncol 22(1):1–5. doi:10.​1097/​CCO.​0b013e328332f8df​ CrossRef PubMed
  8.Moo-Young TA, Panergo J, Wang CE, Patel S, Duh HY, Winchester DJ, Prinz RA, Fogelfeld L (2013) Variations in clinicopathologic characteristics of thyroid cancer among racial ethnic groups: analysis of a large public city hospital and the SEER database. Am J Surg 206(5):632–640. doi:10.​1016/​j.​amjsurg.​2013.​07.​015 CrossRef PubMed
  9.Surveillance E, and End Results Program (2014) Table 26.22 Percent distribution and counts by histology among histologically confirmed cases, 2006–2010. Both sexes by race
  10.Camiel MR, Mule JE, Alexander LL, Benninghoff DL (1968) Association of thyroid carcinoma with Gardner’s syndrome in siblings. N Engl J Med 278(19):1056–1058. doi:10.​1056/​NEJM196805092781​908 CrossRef PubMed
  11.Perrier ND, van Heerden JA, Goellner JR, Williams ED, Gharib H, Marchesa P, Church JM, Fazio VW, Larson DR (1998) Thyroid cancer in patients with familial adenomatous polyposis. World J Surg 22(7):738–742 (discussion 743) CrossRef PubMed
  12.Cetta F, Pelizzo MR, Curia MC, Barbarisi A (1999) Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol 155(1):7–9. doi:10.​1016/​S0002-9440(10)65091-2 CrossRef PubMed PubMedCentral
  13.Harach HR, Williams GT, Williams ED (1994) Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 25(6):549–561CrossRef PubMed
  14.Tomoda C, Miyauchi A, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Kuma S, Kuma K, Kakudo K (2004) Cribriform–morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg 28(9):886–889CrossRef PubMed
  15.Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, Kelley NC, Hamilton SR (1993) Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34(10):1394–1396CrossRef PubMed PubMedCentral
  16.Half E, Bercovich D, Rozen P (2009) Familial adenomatous polyposis. Orphanet J Rare Dis 4:22. doi:10.​1186/​1750-1172-4-22 CrossRef PubMed PubMedCentral
  17.Kennedy RD, Potter DD, Moir CR, El-Youssef M (2014) The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes. J Pediatr Surg 49(1):82–86. doi:10.​1016/​j.​jpedsurg.​2013.​09.​033 CrossRef PubMed
  18.Cruz-Correa M, Diaz-Algorri Y, Mendez V, Vazquez PJ, Lozada ME, Freyre K, Lathroum L, Gonzalez-Pons M, Hernandez-Marrero J, Giardiello F, Rodriguez-Quilichini S (2013) Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes. Fam Cancer 12(3):555–562. doi:10.​1007/​s10689-013-9617-z CrossRef PubMed PubMedCentral
  19.Fritz AG, Percy C, Jack A, Sobin LH, Parking MD (eds) (2000) International classification of disease for oncology, 3rd edn. World Health Organization, Geneva
  20.Reviewing Pathologist Darcy Broughel-Baer DO, M.P.H. (2014) β-catenin testing. Esoterix Genetic Laboratories, New York
  21.Kurihara K, Shimizu S, Chong J, Hishima T, Funata N, Kashiwagi H, Nagai H, Miyaki M, Fukayama M (2000) Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma. Jpn J Cancer Res Gann 91(11):1100–1102CrossRef PubMed
  22.Chew MH, Quah HM, Teh KL, Loi TT, Eu KW, Tang CL (2011) Twenty years of familial adenomatosis polyposis syndromes in the Singapore Polyposis Registry: an analysis of outcomes. Singapore Med J 52(4):246–251PubMed
  23.Bulow C, Bulow S (1997) Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis 12(4):240–242CrossRef PubMed
  24.Steinhagen E, Guillem JG, Chang G, Salo-Mullen EE, Shia J, Fish S, Stadler ZK, Markowitz AJ (2012) The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer 11(4):304–308. doi:10.​1016/​j.​clcc.​2012.​01.​006 CrossRef PubMed
  25.Herraiz M, Barbesino G, Faquin W, Chan-Smutko G, Patel D, Shannon KM, Daniels GH, Chung DC (2007) Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol 5(3):367–373. doi:10.​1016/​j.​cgh.​2006.​10.​019 CrossRef PubMed
  26.Feng X, Milas M, O’Malley M, LaGuardia L, Berber E, Jin J, Metzger R, Mitchell J, Shin J, Burke CA, Kalady M, Church J, Siperstein A (2015) Characteristics of benign and malignant thyroid disease in familial adenomatous polyposis patients and recommendations for disease surveillance. Thyroid 25(3):325–332. doi:10.​1089/​thy.​2014.​0107 CrossRef PubMed
  27.Levy RA, Hui VW, Sood R, Fish S, Markowitz AJ, Wong RJ, Guillem JG (2014) Cribriform–morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer. doi:10.​1007/​s10689-014-9732-5 PubMed
  28.Jarrar AM, Milas M, Mitchell J, Laguardia L, O’Malley M, Berber E, Siperstein A, Burke C, Church JM (2011) Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg 253(3):515–521. doi:10.​1097/​SLA.​0b013e3181fcba8a​ CrossRef PubMed
  29.Plail RO, Bussey HJ, Glazer G, Thomson JP (1987) Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg 74(5):377–380CrossRef PubMed
  30.Septer S, Slowik V, Morgan R, Dai H, Attard T (2013) Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals. Hered Cancer Clin Pract 11(1):13. doi:10.​1186/​1897-4287-11-13 CrossRef PubMed PubMedCentral
  31.Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1(4):229–233CrossRef PubMed
  32.Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, American College of G (2015) ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262. doi:10.​1038/​ajg.​2014.​435 (quiz 263) CrossRef PubMed PubMedCentral
  
• 作者单位：Nicolás Casellas-Cabrera (1)
  Yaritza Díaz-Algorri (1)
  Víctor J. Carlo-Chévere (2)
  María González-Pons (1) (6)
  Natalia Rodríguez-Mañón (1) (6)
  Julyann Pérez-Mayoral (1)
  Carlos Bertrán-Rodríguez (1)
  Marievelisse Soto-Salgado (6) (7)
  Francis M. Giardiello (8)
  Segundo Rodríguez-Quilichini (5)
  Marcia Cruz-Correa (1) (3) (4) (5) (6) (8)
  
  1. University of Puerto Rico Comprehensive Cancer Center, PMB 711 Ave. 89 Ste. 105, San Juan, PR, 00927-6346, USA
  2. Puerto Rico Pathology, 1760 Calle Loíza Cond. Madrid Suite 206, San Juan, PR, 00911, USA
  6. UPR/MDACC Partnership for Excellence in Cancer Research Program, University of Puerto Rico, Medical Sciences Campus, PMB 371 PO BOX 70344, San Juan, PR, 00936-8344, USA
  7. Doctoral Program in Public Health with Specialty in Social Determinants of Health, Department of Social Sciences, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, PR, 00936-5067, USA
  8. Division of Gastroenterology, Department of Medicine, Johns Hopkins University, 600 N. Wolfe Street Sheikh Zayed Tower, Baltimore, MD, 21287, USA
  5. Department of Surgery, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, PR, 00936-5067, USA
  3. Department of Medicine, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, PR, 00936-5067, USA
  4. Department of Biochemistry, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, PR, 00936-5067, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Human Genetics
  Epidemiology
  
• 出版者：Springer Netherlands
• ISSN：1573-7292

文摘

Familial adenomatous polyposis (FAP) is an inherited form of colorectal cancer characterized by hundreds of adenomatous polyps in the colon and rectum. FAP is also associated with thyroid cancer (TC), but the lifetime risk is still unclear. This study reports the standardized incidence ratio (SIR) of TC in Hispanic FAP patients. TC incidence rates in patients with FAP between the periods of January 1, 2006 to December 31, 2013 were compared with the general population through direct database linkage from the Puerto Rico Central Cancer Registry (PRCCR) and the Puerto Rico Familial Colorectal Cancer Registry (PURIFICAR). The study population consisted of 51 Hispanic patients with FAP and 3239 with TC from the general population. The SIR was calculated using the Indirect Method, defined as observed TC incidence among patients with FAP in PURIFICAR’s cohort (2006–2013) divided by the expected TC incidence based on the PR population rates (2006–2010). SIR values were estimated by sex (male, female, and overall). This study received IRB approval (protocol #A2210207). In Hispanic patients with FAP, the SIR (95 % CI) for TC was 251.73 (51.91–735.65), with higher risk for females 461.18 (55.85–1665.94) than males 131.91 (3.34–734.95). Hispanic FAP patients are at a high risk for TC compared to the general population. Our incidence rates are higher than previous studies, suggesting that this community may be at a higher risk for TC than previously assumed. Implementation of clinical surveillance guidelines and regular ultrasound neck screening in Hispanic FAP patients is recommended.